Nonalcoholic fatty liver disease (NAFLD) is a condition in which excess fat accumulates in
the liver of a patient with no history of alcohol abuse or other causes for secondary hepatic …

Improving physical function and mobility in a continuously expanding elderly population
emerges as a high priority of medicine today. Muscle mass, strength/power, and maximal …

Non-alcoholic fatty liver disease (NAFLD) comprising hepatic steatosis, non-alcoholic
steatohepatitis (NASH), and progressive liver fibrosis is considered the most common liver …

With the growing prevalence of obesity, scientific interest in the biology of adipose tissue has
been extended to the secretory products of adipocytes, since they are increasingly shown to …

Adiponectin, the most abundant protein secreted by white adipose tissue, is known for its
involvement in obesity-related disorders such as insulin resistance, type 2 diabetes mellitus …

Adiponectin, an adipocyte-secreted hormone that plays an important role in diabetes and
cardiovascular disease, may also be of importance in the development and progression of …

Context: Adiponectin, an adipocyte-secreted hormone, is associated with insulin resistance
and the metabolic syndrome. Objective: The physiological regulation of circulating …

Diabetic kidney disease (DKD) is a major complication for diabetic patients. Adiponectin is
an insulin sensitizer and anti-inflammatory adipokine and is mainly secreted by adipocytes …

Adiponectin and its receptors play an important role in energy homeostasis and insulin
resistance, but their regulation remains to be fully elucidated. We hypothesized that high-fat …

Adiponectin (APN), a pleiotropic adipokine that exerts anti-inflammatory, antidiabetic, and
antiatherogenic effects through its receptors (AdipoRs), AdipoR1 and AdipoR2, is an …